Synapse - Clinical characteristics and outcomes of stage I diffuse large B cell lymphoma (DLBCL) in the rituximab‐era

Clinical characteristics and outcomes of stage I diffuse large B cell lymphoma (DLBCL) in the rituximab‐era Meeting Abstract

Authors:	Bobillo, S.; Joffe, E.; Lavery, J.; Noy, A.; Palomba, L.; Straus, D. J.; Kumar, A.; Batlevi, C.; Horwitz, S.; Moskowitz, A.; Hamlin, P.; Zelenetz, A.; Matasar, M.; von Keudell, G.; Sermer, D.; Yahalom, J.; Dogan, A.; Seshan, V.; Younes, A.
Abstract Title:	Clinical characteristics and outcomes of stage I diffuse large B cell lymphoma (DLBCL) in the rituximab‐era
Meeting Title:	15th International Conference on Malignant Lymphoma
Journal Title:	Hematological Oncology
Volume:	37
Issue:	Suppl. 2
Meeting Dates:	2019 Jun 18-22
Meeting Location:	Lugano, Switzerland
ISSN:	0278-0232
Publisher:	Wiley Blackwell
Date Published:	2019-06-01
Start Page:	251
End Page:	252
Language:	English
ACCESSION:	137029435
DOI:	10.1002/hon.60_2630
PROVIDER:	EBSCOhost
PROVIDER:	cin20
PUBMED:	31187525
DOI/URL:	http://search.ebscohost.com/login.aspx?direct=true&db=cin20&AN=137029435&site=ehost-live
Notes:	Meeting Abstract: 196 -- Source: cin20